Summary of evidence for management of anxiety and depression in patients with inflammatory bowel disease
10.3760/cma.j.cn115682-20200629-04132
- VernacularTitle:炎症性肠病患者焦虑和抑郁管理的证据总结
- Author:
Lei YANG
1
;
Qiugui BIAN
;
Zheng LIN
;
Rong WANG
;
Zejuan GU
Author Information
1. 江苏省人民医院护理部，南京 210029
- Keywords:
Anxiety;
Depression;
Inflammatory bowel disease;
Evidence summary
- From:
Chinese Journal of Modern Nursing
2021;27(6):754-760
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To retrieve and analyze related evidence for management of anxiety and depression in patients with inflammatory bowel disease and summarize the best evidence.Methods:BMJ Best Practice, Joanna Briggs Institute Evidence-based Healthcare Center Database, UptoDate, National Guideline Clearinghouse (NGC) , National Institute for Health and Care Excellence (NICE) , Scottish Intercollegiate Guidelines Network (SIGN) , World Gastroenterology Organization, PubMed, Cochrane Library, Embase, CINAHL, PsycInfo, China Biology Medicine disc, CNKI and Wanfang Database were searched by computer for guidelines, evidence summaries, expert consensus, best information practice booklet, recommended practices and systematic reviews on management of anxiety and depression in patients with inflammatory bowel disease.The retrieval time was from establishment of the database to April 20, 2020. Quality evaluation and evidence summary of the included literature were conducted.Results:A total of 12 articles were included, including 3 guidelines, 3 expert consensus and 6 systematic reviews. Finally, it was extracted and integrated into 3 levels of screening, evaluation and management, with 20 pieces of evidence. Among them, the management dimension could be refined into 5 aspects including information support, emotional support, psychological intervention, quitting smoking and drinking and exercise.Conclusions:The application of evidence should be adjusted individually according to the institutional environment, existing conditions, wishes of decision makers, wishes of patients and impediments to the application of evidence, so as to manage psychological problems of patients with inflammatory bowel disease in a scientific way and ensure the quality of nursing.
